Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000117041 | SCV000151173 | uncertain significance | not provided | 2013-06-04 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000259152 | SCV000233040 | likely benign | not specified | 2015-06-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000117041 | SCV000513050 | likely benign | not provided | 2020-05-26 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000259152 | SCV000613322 | benign | not specified | 2016-11-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001088786 | SCV000639756 | benign | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313880 | SCV000739067 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-01-27 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000117041 | SCV003799689 | benign | not provided | 2022-03-21 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000259152 | SCV004039292 | benign | not specified | 2023-08-24 | criteria provided, single submitter | clinical testing |